Insider buying last 90 days
$400Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Nov 5 | Breber Pierre R director | Purchase | $400K |
From Form 4 filings, dated to when each was filed.
Clorox closed at $105.53 on 9 November 2026, +5.6% on the day. The price sits between the 50-day ($87.77) and 200-day ($99.37) moving averages, inside a 52-week range of $79.12 to $128.90. The GekkoIndex reads 37.6, in the Distribution zone, down 13.8 points over five sessions. Gekko Fair Value is $164.94, so the price is 36% below it.
The next earnings report is due on 2 February 2027, 79 days away (after close). Over the last 8 reports the company beat the earnings estimate 6 times, with an average move of 5.3% across the report. Smart-money activity over the last 90 days includes 1 open-market insider purchase. Seasonally, the next 20 trading days from this point averaged +1.7% over the last 5 years, rising in 4 of them.
12 firms rate the stock: 0 buy, 9 hold and 3 sell, with a consensus target of $98.65. A typical daily move is about 3.4%, and a typical 20-day move about 4.8%. On the swing-trade checklist, 4 items read supportive and 1 reads as a headwind (gekkoindex).
A plain summary of the figures as of the Nov 9, 2026 close.
Clorox scores 4 supportive, 1 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
4 supportive1 mixed1 headwind
Averages disagree
Close $109.46 sits between the 50-day ($88.77) and 200-day ($99.31) averages, or the averages disagree.
See the chart36.2, Distribution
Reading 36.2 is in the Distribution zone.
See the GekkoIndex34.5% below
Price is 34.5% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: 1 open-market insider purchase. Last 30 days: 1 unusual options signal.
See smart moneyReports in 79 days
Next report Feb 2, 2027, 79 days away — outside a typical 20-trading-day hold.
See earnings+1.9% on average
From this point in the calendar, the next 20 trading days averaged +1.9% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Clorox closed at $109.46 on Nov 13, 2026, +4.5% over the past year, inside a 52-week range of $79.12 to $128.90.
Use the left and right arrow keys to read daily values.
Put CLX on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Clorox makes and sells a wide range of household and professional goods, spanning cleaning supplies, disinfectants, laundry additives, and personal care items. It is widely recognized for well-known names such as Clorox, Pine-Sol, Glad, Kingsford, Brita, and Burt's Bees, which appear on store shelves across many categories from home care to food storage to grilling.
The company organizes its operations into four segments: Health and Wellness, Household, Lifestyle, and International. Health and Wellness covers cleaning and disinfecting products for both homes and professional settings, along with vitamins and supplements sold under labels like RenewLife and NeoCell. Household focuses on cat litter, bags and wraps, and charcoal for the U.S. market, while Lifestyle includes dressings, sauces, natural personal care items, and water filtration systems. The International segment carries a similar mix of products under region-specific and global brand names. Clorox reaches shoppers through retailers, grocery and warehouse stores, pharmacies, pet shops, military exchanges, e-commerce sites, distributors, and its own sales force.
Founded in 1913, Clorox is headquartered in Oakland, California. Its shares are listed on the NYSE under the ticker CLX.
Clorox’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 36.2, in the Distribution zone, down 3.9 points over five sessions.
Down 3.9 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 54 | −1.1% | −1.3% | ||
| Accumulation | 327 | −0.1% | −1.1% | ||
| Neutral | 290 | −0.3% | −1.3% | ||
| Distribution (current zone) | 29 | +0.8% | −0.9% | ||
| Selling | 2 | Too few readings yet | |||
Average CLX share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Distribution readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Distribution zone: Institutions potentially offloading. About the five zones →
Clorox trades 34.5% below Gekko Fair Value of $167.10, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Clorox shares are worth, recalculated every trading day.
$167.10
Gekko Fair Value, Nov 14, 2026
34.5% Undervalued
At the end of Aug 2026 the price was 3.3% below the estimate.
Insiders filed 1 open-market purchase in Clorox worth $400K, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
$400Kin 1 open-market purchase
| Filed | Insider | Type | Value |
|---|---|---|---|
| Nov 5 | Breber Pierre R director | Purchase | $400K |
From Form 4 filings, dated to when each was filed.
No trades in CLX were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Clorox has been buying back its own shares.
From company filings.
1signal, 94% of the flagged premium in calls.
Latest: Bearish flow on Nov 11, $2.51M in unusual premium.
2of the funds Gekko tracks hold CLX.
Clorox reports on Feb 2, 2027, after the close (79 days away), and beat the EPS estimate in 6 of its last 8 reports.
Feb 2, 2027
Expected after the close, 79 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 2, 2026 | $1.55 est $1.07 | $1.91B est $1.88B | +6.6% |
| Aug 3, 2026 | $1.66 est $1.64 | $1.95B est $1.91B | +9.6% |
| Apr 30, 2026 | $1.64 est $1.55 | $1.67B est $1.67B | −8.1% |
| Feb 3, 2026 | $1.39 est $1.43 | $1.67B est $1.64B | +4.0% |
| Nov 3, 2025 | $0.85 est $0.82 | $1.43B est $1.40B | −1.8% |
| Jul 31, 2025 | $2.87 est $2.20 | $1.99B est $1.93B | −2.4% |
| May 5, 2025 | $1.45 est $1.55 | $1.67B est $1.72B | −2.9% |
| Feb 3, 2025 | $1.55 est $1.39 | $1.69B est $1.76B | −6.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Clorox is $97.00, −11.4% from the last close, from 12 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 12 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 4 | Morgan Stanley | $94 | −14.1% |
| Nov 3 | Barclays | $80 | −26.9% |
| Nov 3 | Wells Fargo | $90 | −17.8% |
| Nov 3 | Bank of America Securities | $96 | −12.3% |
| Nov 3 | J.P. Morgan | $86 | −21.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Clorox averaged +1.9% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +1.5% | 4 of 5 |
| Next 10 trading days | +1.4% | 4 of 5 |
| Next 15 trading days | +0.9% | 3 of 5 |
| Next 20 trading days | +1.9% | 3 of 5 |
| Next 30 trading days | +0.1% | 2 of 5 |
For scale, CLX’s typical 20-trading-day move in either direction is about 4.9%.
Clorox’s market cap is $13.24B, with a P/E ratio of 19.2 and revenue of $7.20B over the last twelve months.
Coverage of Clorox this week reads positive: 7 positive, 5 neutral and 2 negative headlines.
Clorox’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGProcter & Gamble | Neutral | 6.7% below |
| CLColgate-Palmolive | Neutral | 7.5% below |
| ELEstee Lauder Companies | Neutral | 13.8% above |
| KVUEKenvue | Neutral | 1.0% below |
| KMBKimberly-Clark | Neutral | 7.4% below |
| CHDChurch & Dwight | Neutral | 8.7% above |
A peer links to its own page where one exists.
Clorox’s market cap is $13.24B at the Nov 13, 2026 close of $109.46, with 120.9M shares outstanding. The shares trade on a P/E ratio of 19.2.
The consensus analyst 12-month price target for Clorox is $97.00, −11.4% from the last close. Of the 12 firms that rated the stock in the last 90 days, 0 rate it a buy, 9 a hold and 3 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Clorox is undervalued: the Nov 13, 2026 close of $109.46 is 34.5% below Gekko Fair Value of $167.10. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Clorox is expected to report on Feb 2, 2027, after the market closes (79 days away). Analysts expect earnings of $0.98 per share on revenue of $1.87B. Clorox beat the earnings estimate in 6 of its last 8 reports, moving 5.3% on average across the report.
Clorox’s 52-week high is $128.90 and its 52-week low is $79.12; it closed at $109.46 on Nov 13, 2026, +4.5% over the past year. Over the last five years the shares peaked at $186.86 on Jan 14, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (fair value, smart money, earnings risk and seasonality), 1 as mixed (trend) and 1 as a headwind (gekkoindex). The checklist is a description of current data, not a recommendation.
Gekko flagged 1 unusual options signal in Clorox over the last 30 days, with $2.36M of flagged premium in calls and $148K in puts. The latest, bearish flow, was on Nov 11, 2026 with $2.51M in unusual premium. The signal-by-signal table is in Gekko.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.